Follow
Jayaganesh Natarajan
Jayaganesh Natarajan
Verified email at ntu.edu.sg
Title
Cited by
Cited by
Year
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro
JM Saul, A Annapragada, JV Natarajan, RV Bellamkonda
Journal of Controlled Release 92 (1-2), 49-67, 2003
3822003
Sustained-release from nanocarriers: a review
JV Natarajan, C Nugraha, XW Ng, S Venkatraman
Journal of Controlled Release 193, 122-138, 2014
2682014
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
JV Natarajan, M Ang, A Darwitan, S Chattopadhyay, TT Wong, ...
International journal of nanomedicine, 123-131, 2012
1702012
Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma
JV Natarajan, A Darwitan, VA Barathi, M Ang, HM Htoon, F Boey, KC Tam, ...
ACS nano 8 (1), 419-429, 2014
1212014
Folate targeting of drug carriers: a mathematical model
KB Ghaghada, J Saul, JV Natarajan, RV Bellamkonda, AV Annapragada
Journal of controlled release 104 (1), 113-128, 2005
1202005
Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye
JV Natarajan, S Chattopadhyay, M Ang, A Darwitan, S Foo, M Zhen, ...
PloS one 6 (9), e24513, 2011
1082011
Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops
TT Wong, GD Novack, JV Natarajan, CL Ho, HM Htoon, SS Venkatraman
Drug delivery and translational research 4, 303-309, 2014
692014
Polymer-and liposome-based nanoparticles in targeted drug delivery
SS Venkatraman, LL Ma, JV Natarajan, S Chattopadhyay
Front Biosci (Schol Ed) 2, 801-814, 2010
692010
Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab
RR Joseph, DWN Tan, MRM Ramon, JV Natarajan, R Agrawal, TT Wong, ...
Scientific Reports 7 (1), 16803, 2017
342017
Drug, delivery and devices for diabetic retinopathy (3Ds in DR)
J Nirmal, K Radhakrishnan, M Moreno, JV Natarajan, A Laude, TH Lim, ...
Expert Opinion on Drug Delivery 13 (11), 1625-1637, 2016
162016
Liposomal formulation for ocular drug delivery
S Venkatraman, JV Natarajan, T Wong, YCF Boey
US Patent 10,272,040, 2019
142019
Stable liposomal formulations for ocular drug delivery
S Venkatraman, JV Natarajan, T Howden, F Boey
US Patent 9,956,195, 2018
82018
Sustained timolol maleate delivery from liposomes for glaucoma therapy and occular hypertension
S Venkatraman, YCF Boey, JV Natarajan
US Patent App. 15/513,010, 2017
52017
Liposomal formulations
S Venkatraman, Y Huang, A Nagle, JV Natarajan, NDM Foin, TT Chong, ...
US Patent App. 16/332,725, 2019
12019
Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them
S Venkatraman, JV Natarajan, A Darwitan
US Patent App. 16/063,062, 2018
12018
Nanoliposomes for sustained delivery of tacrolimus for treatment of anterior segment eye diseases
S Venkatraman, JV Natarajan, YCF Boey, JS Mehta, TTL Howden, ...
US Patent App. 18/308,557, 2023
2023
Nanoliposomes for sustained delivery of tacrolimus for treatment of anterior segment eye diseases
S Venkatraman, JV Natarajan, YCF Boey, JS Mehta, TTL Howden, XW Ng, ...
US Patent 11,672,784, 2023
2023
Drug, delivery and devices for diabetic retinopathy (3Ds in DR)
JV Natarajan, A Laude, TH Lim, SS Venkatraman, R Agrawal, J Nirmal, ...
2016
Studies Of Ciprofloxacin Hydrochloride Loaded Liposomes In Ocular Delivery: An Evaluation Of In-vitro Drug Release
JV Natarajan, S Chattopadhyay, SS Venkatraman, T Wong
Investigative Ophthalmology & Visual Science 52 (14), 422-422, 2011
2011
Supplementary information Sustained Drug Release in Nanomedicine: A Long-Acting Nanocarrier-Based Formulation for Glaucoma
JV Natarajan, A Darwitan, VA Barathi, M Ang, HM Htoon, F Boey, KC Tam, ...
The system can't perform the operation now. Try again later.
Articles 1–20